Global Endocrinology Drugs Market 2018-2022 | Increasing Incidence of Endocrine Disorders to Boost Demand | Technavio
LONDON--(BUSINESS WIRE)--Oct 9, 2018-- analysts forecast the global endocrinology drugs market to grow at a CAGR of over 6% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181009005735/en/
Technavio analysts forecast the global endocrinology drugs market to grow at a CAGR of over 6% by 2022. (Graphic: Business Wire)
The association between obesity and endocrine disorders is one of the major trends being witnessed in the . The increasing incidence of obesity may be associated with the high incidence of endocrine disorders such as , hypothyroidism, and PCOS. Obesity may also be associated with rare endocrinology disorders such as Crushing’s syndrome and hypothyroidism. These disorders may be causative factors for the development of obesity in some cases or maybe the secondary effects of obesity.
According to Technavio analysts, one of the key factors contributing to the growth of the global endocrinology drugs market is the increasing incidence of endocrine disorders:
Global endocrinology drugs market: Increasing incidence of endocrine disorders
The increase in the incidence of endocrine disorders may be due to the rising aging population globally. The aging population is at a high-risk of hormone disorders that increase with age. With advances in technology, life expectancy is increasing. This increases the proportion of aging and dependent population, which, in turn, poses a significant burden on public healthcare spending as well as the average spending per person on healthcare.
According to a senior analyst at Technavio for research on infectious and rare diseases, “Diabetes is the most common disorder, and its incidence is increasing globally, posing as a major public health issue. The risk factors are generally known to be a genetic and poor lifestyle and dietary habits. The incidence of diabetes also has a high economic impact globally due to the costs associated such as hospital costs, purchase of drugs and biologics, primary care visits, and specialized visits.”
Global endocrinology drugs market: Segmentation analysis
The global endocrinology drugs market research report provides market segmentation by therapy area (diabetes drugs, thyroid hormone disorder drugs, HGH, and testosterone replacement therapy), and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The Americas held the largest share of the market in 2017, accounting for close to 52% share. It was followed by EMEA and APAC respectively. However, the incidence patterns of the disease are rising in APAC. For instance, Asia accounts for about 60% of the world diabetic population with almost one-half of the population in China and India combined.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181009005735/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA AFRICA MIDDLE EAST
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES RESEARCH SCIENCE
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 10/09/2018 10:14 AM/DISC: 10/09/2018 10:13 AM